GREEN CROSS WellBeing Corporation (234690) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.037x

Based on the latest financial reports, GREEN CROSS WellBeing Corporation (234690) has a cash flow conversion efficiency ratio of -0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.97 Billion ≈ $-2.69 Million USD) by net assets (₩107.17 Billion ≈ $72.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See GREEN CROSS WellBeing Corporation (234690) defensive interval to measure how many days the company can operate on defensive assets alone.

GREEN CROSS WellBeing Corporation - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how GREEN CROSS WellBeing Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.

GREEN CROSS WellBeing Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GREEN CROSS WellBeing Corporation ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Patria Bank SA RO:PBK	0.240x
EverFocus Electronics Corp TW:5484	-0.043x
Uttam Sugar Mills Limited NSE:UTTAMSUGAR	0.747x
Polytec Holding AG VI:PYT	0.182x
CO2 Energy Transition Corp. Common Stock NASDAQ:NOEM	-0.002x
Bulten AB ST:BULTEN	0.027x
Eastland Equity Bhd KLSE:2097	0.051x
Seoul Electronics & Telecom Co. Ltd KQ:027040	-0.173x

Annual Cash Flow Conversion Efficiency for GREEN CROSS WellBeing Corporation (2016–2025)

The table below shows the annual cash flow conversion efficiency of GREEN CROSS WellBeing Corporation from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see GREEN CROSS WellBeing Corporation (234690) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩112.70 Billion ≈ $76.38 Million	₩5.73 Billion ≈ $3.88 Million	0.051x	-61.08%
2024-12-31	₩104.95 Billion ≈ $71.13 Million	₩13.71 Billion ≈ $9.29 Million	0.131x	+1372.80%
2023-12-31	₩100.39 Billion ≈ $68.03 Million	₩-1.03 Billion ≈ $-698.19K	-0.010x	-154.11%
2022-12-31	₩96.16 Billion ≈ $65.17 Million	₩1.82 Billion ≈ $1.24 Million	0.019x	-80.72%
2021-12-31	₩88.30 Billion ≈ $59.84 Million	₩8.68 Billion ≈ $5.89 Million	0.098x	+231.95%
2020-12-31	₩83.08 Billion ≈ $56.30 Million	₩-6.19 Billion ≈ $-4.20 Million	-0.075x	-214.49%
2019-12-31	₩83.17 Billion ≈ $56.36 Million	₩5.41 Billion ≈ $3.67 Million	0.065x	-65.52%
2018-12-31	₩28.84 Billion ≈ $19.55 Million	₩5.45 Billion ≈ $3.69 Million	0.189x	+14.22%
2017-12-31	₩24.84 Billion ≈ $16.83 Million	₩4.11 Billion ≈ $2.78 Million	0.165x	+321.59%
2016-12-31	₩20.94 Billion ≈ $14.19 Million	₩-1.56 Billion ≈ $-1.06 Million	-0.075x	--

About GREEN CROSS WellBeing Corporation

KQ:234690 Korea Biotechnology

Market Cap

$98.85 Million

₩145.87 Billion KRW

Market Cap Rank

#19306 Global

#948 in Korea

Share Price

₩8220.00

Change (1 day)

-3.29%

52-Week Range

₩7850.00 - ₩15100.00

All Time High

₩16468.03